Here we demonstrate that a novel HDAC inhibitor, CG200745, selectively targets Hippo signalling in cholangiocarcinoma cells to suppress proliferation and induce apoptosis, acting either alone or synergistically with conventional chemotherapy drugs. The gene discussed is HDAC9; the disease is cholangiocarcinoma.